Steffan Vartanian
Papers
1
Total Citations
114
H-Index
1
About
Steffan Vartanian is a distinguished researcher whose work lies at the intersection of chemical biology, proteomics, and cancer therapeutics. His most impactful contribution centers on the KEAP1/Nrf2 pathway, a critical cellular defense mechanism against oxidative stress that is frequently hijacked in cancers like non-small cell lung cancer. In his landmark 2015 study, which has garnered 114 citations, Vartanian employed advanced mass spectrometry profiling to reveal that brusatol, a natural compound, acts as a potent inhibitor of global protein synthesis. This discovery was pivotal, as it provided a mechanistic explanation for brusatol’s ability to suppress Nrf2 activity—a long-sought goal for treating tumors with constitutive Nrf2 activation. By elegantly linking chemical inhibition to proteomic analysis, Vartanian not only identified a novel therapeutic strategy but also established a powerful methodological framework for studying protein synthesis dynamics. His work has profound implications for developing targeted therapies against oxidative stress-driven malignancies, making him a key figure in the ongoing battle against drug-resistant cancers.
Research Focus
Key Achievements
Top Papers
- 1